SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-292949
Filing Date
2011-11-02
Accepted
2011-11-02 17:00:20
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d238958d10q.htm 10-Q 332863
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d238958dex311.htm EX-31.1 10527
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d238958dex312.htm EX-31.2 10709
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 d238958dex321.htm EX-32.1 3383
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 d238958dex322.htm EX-32.2 3586
  Complete submission text file 0001193125-11-292949.txt   1403335

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chtp-20110930.xml EX-101.INS 111898
7 XBRL TAXONOMY EXTENSION SCHEMA chtp-20110930.xsd EX-101.SCH 14317
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20110930_cal.xml EX-101.CAL 27666
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20110930_def.xml EX-101.DEF 10730
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20110930_lab.xml EX-101.LAB 119532
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20110930_pre.xml EX-101.PRE 86721
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 111175133
SIC: 2836 Biological Products, (No Diagnostic Substances)